4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023564
CHIEF ACCOUNTING OFFICER sold 11,000 shares at $34.84 ($383,240)
- CHIEF ACCOUNTING OFFICER acquired 20,627 shares (option exercise)
- CHIEF ACCOUNTING OFFICER gave up 4,657 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Option exercise 10b5-1 | +2,363 | 35,404 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Option exercise 10b5-1 | +2,557 | 37,961 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Option exercise 10b5-1 | +3,933 | 41,894 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Shares withheld for taxes 10b5-1 | −4,282 | $33.49 | $143,404 | 37,612 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-02 | Option exercise 10b5-1 | +774 | 38,386 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-02 | Shares withheld for taxes 10b5-1 | −375 | $34.28 | $12,855 | 38,011 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-03 | Option exercise 10b5-1 | +11,000 | $17.92 | $197,120 | 49,011 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-03 | Sale 10b5-1 | −11,000 | $34.84 | $383,240 | 38,011 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Grant or award · Restricted Share Unit 10b5-1 | +10,575 | 10,575 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Grant or award · Share Option 10b5-1 | +21,150 | 21,150 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Option exercise · Restricted Share Unit 10b5-1 | −2,363 | 7,087 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Option exercise · Restricted Share Unit 10b5-1 | −2,557 | 5,115 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-01 | Option exercise · Restricted Share Unit 10b5-1 | −3,933 | 3,932 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-02 | Option exercise · Restricted Share Unit 10b5-1 | −774 | 0 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-09-03 | Option exercise · Share Option 10b5-1 | −11,000 | 0 | D | ||
| Open-market sales · 11,000 sh · avg $34.84 · $383,240 | |||||||
Loading xslF345X05/form4-09032025_080915.xml…